New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?
Anaemia is a condition that frequently occurs in patients with cancer, but a recent survey has cast doubt over whether it is being appropriately treated. These findings are disappointing considering the wealth of data showing the effectiveness of epoetin therapy in patients with cancer. Recently, evidence-based guidelines have been published that aim to provide physicians with the latest information required for optimal management of anaemia in patients with cancer. By increasing physician awareness of the appropriate therapy for anaemia management, more patients may receive the benefits of epoetin therapy.
Birgegård
Gunnar
G
Department of Hematology, University Hospital, Uppsala, Sweden. gunnarbirgegard@medsci.uu.se
Bokemeyer
Carsten
C
D000747:Anemia, Hypochromic / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology*; D004921:Erythropoietin / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011994:Recombinant Proteins
D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin